Pfizer Inc.

PFE · NYSE

Price$0.00+0.00 (+0.00%)

Price History

Volume & Moving Averages

Price50D200D

Analyst Price Target

$0.00▲ 0.0% above current price

Range: $0.00 – $0.00 · 0 analysts

Based on Wall Street analyst estimates — not a Stockinder prediction.

About the company

Jarvis is thinking

Key Metrics

Report card

Open as standalone page ↗

Jarvis is thinking

Recent Notable Coverage

Jarvis is thinking

Report Card

Growth

Health

Risk

Value

Quality

Ownership

Insider and institutional holdings, from Yahoo Finance — for Indian companies this roughly tracks promoter (insiders) and combined FII/DII (institutions) stakes, though not split out the same way a shareholding-pattern filing would.

Insiders0.1%

Institutions69.2%

Public / Other

	You	Peer avg
P/E	37.4	51.4
Revenue Growth	+2.6%	+16.3%
ROE	5.0%	45.4%

Income Statement

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31
Total money the company brought in from its core business during the period, before any costs are subtracted.	$1.80B	$1.60B	$50.91B	$100.33B	$81.29B	$41.91B	$51.75B	$53.65B	$52.55B	$52.82B
The direct costs of producing what was sold — raw materials, manufacturing, direct labor.	$16.07B	$17.85B	$24.95B	$34.34B	$30.82B	$8.69B	$10.22B	$11.25B	$11.24B	$12.33B
The company's bottom-line profit after all expenses, interest, and taxes are subtracted.	$41.00M	$31.00M	$39.00M	$35.00M	$45.00M	$36.00M	$29.00M	$11.15B	$21.31B	$7.21B
Net income divided by the number of shares outstanding — profit attributable to each share.	$1.00	$1.00	$0.00	$5.00	$3.92	$1.73	$2.00	$1.00	$3.00	$1.00
Like basic EPS, but accounts for shares that could be created from stock options or convertible securities — a more conservative per-share profit figure.	$1.00	$1.00	$0.00	$5.00	$3.85	$1.71	$2.00	$1.00	$3.00	$1.00

Balance Sheet

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31
Cash and highly liquid short-term investments the company can access almost immediately.	$1.14B	$1.04B	$2.85B	$416.00M	$1.94B	$1.78B	$1.30B	$1.14B	$1.34B	$2.60B
Everything the company owns that has value — cash, property, inventory, investments, and more.	$208.00B	$213.00B	$227.00B	$197.00B	$181.00B	$154.23B	$167.00B	$159.42B	$171.80B	$172.00B
All of the company's interest-bearing borrowings, short and long term combined.	$65.15B	$63.95B	$72.35B	$35.95B	$38.24B	$39.84B	$52.15B	$41.74B	$43.49B	$42.09B
Everything the company owes — debt, unpaid bills, and other obligations.	$121.39B	$124.90B	$137.21B	$101.29B	$104.01B	$90.76B	$104.04B	$95.66B	$100.14B	$111.78B
What would be left for shareholders if the company sold all its assets and paid off all its debts — total assets minus total liabilities.	$86.48B	$88.20B	$89.01B	$95.66B	$77.20B	$63.24B	$63.14B	$63.41B	$71.31B	$59.54B

Cash Flow Statement

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31
Actual cash generated by the core business, as opposed to accounting profit, which can include non-cash items.	$11.70B	$12.74B	$8.70B	$29.27B	$32.92B	$10.59B	$12.59B	$15.83B	$16.47B	$15.90B
Cash spent on physical assets like property, equipment, and infrastructure to maintain or grow the business.	$2.63B	$2.91B	$3.91B	$3.24B	$2.71B	$2.25B	$2.18B	$2.04B	$1.96B	$1.82B
Cash left over after capital expenditures — money the company could use for dividends, buybacks, debt repayment, or reinvestment.	$9.07B	$9.84B	$4.79B	$26.03B	$30.21B	$8.33B	$10.41B	$13.79B	$14.51B	$14.08B

Pfizer Inc.

Price History

Volume & Moving Averages

Analyst Price Target

About the company

Key Metrics

Report card

Jarvis Analysis

Recent Notable Coverage

Report Card

Ownership

Quick Actions

Reports & Coverage

Con Call Reports

Board of Directors / Annual Reports

Recent Articles

Peer Comparison

Income Statement

Balance Sheet

Cash Flow Statement